A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension

References

• HatanoS, StrasserT, World Health Organization. Primary pulmonary hypertension: report on a WHO meeting, Geneva, 15-17 October / 1973 edited by Shuichi Hatano and Toma Strasser. World Health Organization; 1975 Available from: http://www.who.int/iris/handle/10665/39094. Accessed 25, 2020.
   Google Scholar
• StammJA, McVerryBJ, MathierMA, DonahoeMP, SaulMI, GladwinMT. Doppler-defined pulmonary hypertension in medical intensive care unit patients: retrospective investigation of risk factors and impact on mortality. Pulm Circ. 2011;1(1):95–102. doi:10.4103/2045-8932.7810422034595
   PubMedGoogle Scholar
• KaestnerM, SchranzD, WarneckeG, ApitzC, HansmannG, MieraO. Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart Br Card Soc. 2016;102 Suppl 2:ii57–66.
   PubMed Web of Science ®Google Scholar
• LevitzkyMG. Blood flow to the lung In: Pulmonary Physiology. 9th ed. New York, NY: McGraw-Hill Education;2017 Available from: accessmedicine.mhmedical.com/content.aspx?aid=1149865170. Accessed 1221, 2017.
   Google Scholar
• MoloneyED, EvansTW. Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur Respir J. 2003;21(4):720–727. doi:10.1183/09031936.03.0012010212762363
   PubMed Web of Science ®Google Scholar
• SmuldersYM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res. 2000;48(1):23–33. doi:10.1016/S0008-6363(00)00168-111033105
   PubMed Web of Science ®Google Scholar
• ViaG, BraschiA. Pathophysiology of severe pulmonary hypertension in the critically ill patient. Minerva Anestesiol. 2004;70(4):233–237.15173702
   PubMedGoogle Scholar
• MatthewsJC, McLaughlinV. Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev. 2008;4(1):49–59. doi:10.2174/15734030878356538419924277
   PubMedGoogle Scholar
• VlahakesGJ, TurleyK, HoffmanJI. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation. 1981;63(1):87–95. doi:10.1161/01.CIR.63.1.877438411
   PubMed Web of Science ®Google Scholar
• IgnarroLJ, BugaGM, WoodKS, ByrnsRE, ChaudhuriG. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84(24):9265–9269. doi:10.1073/pnas.84.24.92652827174
   PubMed Web of Science ®Google Scholar
• PalmerRM, FerrigeAG, MoncadaS. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524–526. doi:10.1038/327524a03495737
   PubMed Web of Science ®Google Scholar
• HughesMN. Chemistry of nitric oxide and related species. Methods Enzymol. 2008;436:3–19.18237624
   PubMed Web of Science ®Google Scholar
• FrostellC, FratacciMD, WainJC, JonesR, ZapolWM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991;83(6):2038–2047. doi:10.1161/01.CIR.83.6.20382040056
   PubMed Web of Science ®Google Scholar
• AlbertM, CorsilliD, WilliamsonDR, et al. Comparison of inhaled milrinone, nitric oxide and prostacyclin in acute respiratory distress syndrome. World J Crit Care Med. 2017;6(1):74–78. doi:10.5492/wjccm.v6.i1.7428224110
   PubMedGoogle Scholar
• BeghettiM, Spahr-SchopferI, MensiN, MorelDR, RimensbergerPC. Effects of inhaled nitric oxide and intravenous magnesium sulphate, alone and in combination, in a porcine model of hypoxic pulmonary hypertension. Med Sci Monit Int Med J Exp Clin Res. 2003;9(6):BR193–198.
   Google Scholar
• BigatelloLM, HurfordWE, KacmarekRM, RobertsJD, ZapolWM. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology. 1994;80(4):761–770. doi:10.1097/00000542-199404000-000078024129
   PubMed Web of Science ®Google Scholar
• RossaintR, FalkeKJ, LópezF, SlamaK, PisonU, ZapolWM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328(6):399–405. doi:10.1056/NEJM1993021132806058357359
   PubMed Web of Science ®Google Scholar
• KaramO, GebistorfF, WetterslevJ, AfshariA. The effect of inhaled nitric oxide in acute respiratory distress syndrome in children and adults: a Cochrane Systematic Review with trial sequential analysis. Anaesthesia. 2017;72(1):106–117. doi:10.1111/anae.1362827762438
   PubMed Web of Science ®Google Scholar
• PedersenJ, HedegaardER, SimonsenU, KrügerM, InfangerM, CurrentGD. Future treatments for persistent pulmonary hypertension in the Newborn. Basic Clin Pharmacol Toxicol. 2018;123(4):392–406. doi:10.1111/bcpt.1305129855164
   PubMed Web of Science ®Google Scholar
• Monsalve-NaharroJÁ, Domingo-ChivaE, García CastilloS, Cuesta-MonteroP, Jiménez-VizueteJM. Inhaled nitric oxide in adult patients with acute respiratory distress syndrome. Farm Hosp. 2017;41(2):292–312.28236803
   PubMed Web of Science ®Google Scholar
• ClaessonJ, FreundlichM, GunnarssonI, et al. Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome. Acta Anaesthesiol Scand. 2016;60(6):697–709. doi:10.1111/aas.2016.60.issue-626988416
   PubMed Web of Science ®Google Scholar
• MeadeMO, JackaMJ, CookDJ, et al. Survey of interventions for the prevention and treatment of acute respiratory distress syndrome. Crit Care Med. 2004;32(4):946–954. doi:10.1097/01.CCM.0000120056.76356.AD15071383
   PubMed Web of Science ®Google Scholar
• BeckmanJS, BeckmanTW, ChenJ, MarshallPA, FreemanBA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;87(4):1620–1624. doi:10.1073/pnas.87.4.16202154753
   PubMed Web of Science ®Google Scholar
• LundinS, MangH, SmithiesM, StenqvistO, FrostellC. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med. 1999;25(9):911–919. doi:10.1007/s00134005098210501745
   PubMed Web of Science ®Google Scholar
• RolleyL, BandesheH, BootsRJ. “Safe” methaemoglobin concentrations are a mortality risk factor in patients receiving inhaled nitric oxide. Anaesth Intensive Care. 2011;39(5):919–925. doi:10.1177/0310057X110390051921970140
   PubMed Web of Science ®Google Scholar
• GuarínM, DawsonCA, NelinLD. The arterial site of action of nitric oxide in the neonatal pig lung determined by microfocal angiography. Lung. 2001;179(1):43–55. doi:10.1007/s00408000004611479693
   PubMed Web of Science ®Google Scholar
• RimarS, GillisCN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation. 1993;88(6):2884–2887. doi:10.1161/01.CIR.88.6.28848252701
   PubMed Web of Science ®Google Scholar
• MillerMR, MegsonIL. Recent developments in nitric oxide donor drugs. Br J Pharmacol. 2007;151(3):305–321. doi:10.1038/sj.bjp.070722417401442
   PubMed Web of Science ®Google Scholar
• CockrillBA, KacmarekRM, FiferMA, et al. Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension. Chest. 2001;119(1):128–136. doi:10.1378/chest.119.1.12811157594
   PubMed Web of Science ®Google Scholar
• ButlerAR, GlidewellC, McGinnisJ, BissetWI. Further investigations regarding the toxicity of sodium nitroprusside. Clin Chem. 1987;33(4):490–492. doi:10.1093/clinchem/33.4.4903829378
   PubMed Web of Science ®Google Scholar
• AgvaldP, AddingLC, GustafssonLE, PerssonMG. Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo. Eur J Pharmacol. 1999;385(2–3):137–145. doi:10.1016/S0014-2999(99)00720-710607869
   PubMed Web of Science ®Google Scholar
• TiltonRG, BrockTA, DixonRA. Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension. Expert Opin Investig Drugs. 2001;10(7):1291–1308. doi:10.1517/13543784.10.7.1291
   PubMed Web of Science ®Google Scholar
• BauerJA, NolanT, FungHL. Vascular and hemodynamic differences between organic nitrates and nitrites. J Pharmacol Exp Ther. 1997;280(1):326–331.8996213
   PubMed Web of Science ®Google Scholar
• NilssonKF, LundgrenM, AgvaldP, AddingLC, LinnarssonD, GustafssonLE. Formation of new bioactive organic nitrites and their identification with gas chromatography–mass spectrometry and liquid chromatography coupled to nitrite reduction. Biochem Pharmacol. 2011;82(3):248–259. doi:10.1016/j.bcp.2011.04.00521549687
   PubMed Web of Science ®Google Scholar
• NilssonKF, GoździkW, FrostellC, et al. Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs. Drug Des Devel Ther. 2018;12:685–694. doi:10.2147/DDDT
   PubMed Web of Science ®Google Scholar
• AbmanSH, KinsellaJP. Inhaled ethyl nitrite gas for persistent pulmonary hypertension in infants. Lancet Lond Engl. 2002;360(9350):2076–2077;author reply 2077. doi:10.1016/S0140-6736(02)12000-9
   Google Scholar
• LavonO, BenturY. Does amyl nitrite have a role in the management of pre-hospital mass casualty cyanide poisoning? Clin Toxicol Phila Pa. 2010;48(6):477–484. doi:10.3109/15563650.2010.505573
   PubMed Web of Science ®Google Scholar
• MoyaMP, GowAJ, CaliffRM, GoldbergRN, StamlerJS. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet Lond Engl. 2002;360(9327):141–143. doi:10.1016/S0140-6736(02)09385-6
   PubMed Web of Science ®Google Scholar
• NilssonKF, GustafssonLE. Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism. Pharmacol Res Perspect. 2019;7(1):e00462. doi:10.1002/prp2.2019.7.issue-130693089
   PubMed Web of Science ®Google Scholar
• Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32010L0063&rid=1. Accessed 25, 2020.
   Google Scholar
• BenjaminiY, HochbergY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289–300.
   Google Scholar
• INOmax: EPAR - Scientific discussion. 5 2006 Available from: https://www.ema.europa.eu/en/documents/scientific-discussion/inomax-epar-scientific-discussion_en.pdf. Accessed 523, 2019.
   Google Scholar
• EtchesPC, FinerNN, BarringtonKJ, GrahamAJ, ChanWK. Nitric oxide reverses acute hypoxic pulmonary hypertension in the newborn piglet. Pediatr Res. 1994;35(1):15–19. doi:10.1203/00006450-199401000-000048134192
   PubMed Web of Science ®Google Scholar
• GuthrieSO, WalshWF, AutenK, ClarkRH. Initial dosing of inhaled nitric oxide in infants with hypoxic respiratory failure. J Perinatol off J Calif Perinat Assoc. 2004;24(5):290–294.
   PubMedGoogle Scholar
• GibsonQH, RoughtonFJ. The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol. 1957;136(3):507–524. doi:10.1113/jphysiol.1957.sp00577713429517
   PubMed Web of Science ®Google Scholar
• WrightRO, LewanderWJ, WoolfAD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34(5):646–656. doi:10.1016/S0196-0644(99)70167-810533013
   PubMed Web of Science ®Google Scholar
• NilssonKF, SandinJ, GustafssonLE, FrithiofR. The novel nitric oxide donor PDNO attenuates ovine ischemia-reperfusion induced renal failure. Intensive Care Med Exp. 2017;5(1):29. doi:10.1186/s40635-017-0143-428600797
   PubMed Web of Science ®Google Scholar
• AlbertJ, HarbutP, ZielińskiS, et al. Prolonged exposure to inhaled nitric oxide does not affect haemostasis in piglets. Intensive Care Med. 2007;33(9):1594–1601. doi:10.1007/s00134-007-0666-317497125
   PubMed Web of Science ®Google Scholar
• MélotC, VermeulenF, MaggioriniM, GilbertE, NaeijeR. Site of pulmonary vasodilation by inhaled nitric oxide in microembolic lung injury. Am J Respir Crit Care Med. 1997;156(1):75–85. doi:10.1164/ajrccm.156.1.96030419230729
   PubMed Web of Science ®Google Scholar
• PrestonIR, SaglianiKD, RobertsKE, et al. Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension. Pulm Circ. 2013;3(1):68–73. doi:10.4103/2045-8932.10991623662176
   PubMed Web of Science ®Google Scholar
• WortSJ, EvansTW. The role of the endothelium in modulating vascular control in sepsis and related conditions. Br Med Bull. 1999;55(1):30–48. doi:10.1258/000714299190228610695078
   PubMed Web of Science ®Google Scholar
• Hambraeus-JonzonK, BindslevL, FrostellC, HedenstiernaG. Individual lung blood flow during unilateral hypoxia: effects of inhaled nitric oxide. Eur Respir J. 1998;11(3):565–570.9596103
   PubMed Web of Science ®Google Scholar